DDMAC warning and untitled letters in 2008 total 21

The FDA's Division of Drug Marketing, Advertising and Communications issued 21 warning and untitled letters in 2008 – scarcely more than the 20 letters the unit sent out in 2007.

As in 2007, 10 were “warning letters,” the remainder being of the somewhat less serious “untitled” variety.

In 2006, DDMAC issued 22 letters reprimanding drug manufacturers for promotional materials deemed violative of the Food, Drug and Cosmetics Act, typically for overstating efficacy and/or underplaying risks, but 14 of those were warning letters.